Skip to main content Skip to footer

Home
About
News
Downloads
Contact

Home
About
News
Downloads
Contact

Day: January 1, 2020

January 1, 2020
Manchester, England, 14 January 2020 – Phagenesis Ltd., a pioneering leader in the treatment of dysphagia, is pleased to announce today that the…

Phagenesis Headquarters
Unit 18 Enterprise House, Manchester Science Park, Manchester M15 6SE, United Kingdom

+44 (0)161 820 4525

[email protected]

Phagenesis operates from the UK, Germany, Austria and the United States

© Phagenesis Limited 2025. All rights reserved.
The Phagenyx® system is CE marked and is available for sale only in the European Economic Area, UK and Switzerland.

© Phagenesis Inc. 2025. All rights reserved.
FDA has provided de novo classification for the Phagenyx® System and it is available for sale in the United States.

Terms and Conditions Privacy Policy Cookies Policy